Important Info About the Allergan Breast Implant Recall
Breast implants are generally safe, but as with all procedures, there are risks. Last week, the FDA requested that Allergan recall its textured breast implants, due to the risk of breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL)—a rare cancer.
WHAT TO KNOW
- Recalled implants make up less than 5% of sold implants in U.S.
- Only textured implants have been linked to this cancer.
- Risk of BIA-ALCL is 1 in 3,200.
- FDA is not recommending implant removal if you have no symptoms.
WHAT TO DO
- Check your implant ID card for information on what type of implant you have.
- Talk to your surgeon if you have any questions, symptoms or concerns.
For the past several years Dr. Bednar has specialized in natural fat transfer breast augmentation and used very few Allergan implant products. Please feel free to contact our office if you have any concerns about your implants at 704-377-6700
FDA Announces New Policies, Won’t Ban Textured Implants
If you’re one of the millions of women in the U.S. who has—or is considering—breast implants, you may already know about the Food and Drug Administration (FDA) hearings in March about implant safety concerns. Last week, a new FDA statement outlined a slew of new policies in response to the hearings. Most notably, they chose not to ban or restrict the use of textured implants, despite their link to a rare form of cancer: breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
The FDA says that for now, they’re focusing on informing women and providers about the increased risk of textured implants, while strengthening the evidence that will inform future regulations. They also noted that outside the U.S., textured implants are far more common (upwards of 80%, compared to only 10% here), including “macro-textured” implants not available in to patients in the U.S.